Clinical effect of high dose of calcitriol on end-stage renal disease patients complicated with secondary hyperparathyroidism
10.3969/j.issn.1005-1678.2017.01.065
- VernacularTitle:大剂量骨化三醇冲击疗法对终末期肾病患者并发继发性甲状旁腺功能亢进的疗效
- Author:
Yaqun LIANG
;
Wenli HOU
;
Miao DONG
- Keywords:
calcitriol;
end stage renal disease;
secondary hyperparathyroidism;
quality of life
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(1):220-222
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical effect of high dose of calcitriol on end-stage renal disease (ESRD) in patients with secondary hyperparathyroidism (SHPT). Methods The clinical data of patients with ESRDcomplicated with SHPT were retrospectively analyzed. According to the treatment method were divided into control group and observation group, the control group were given conventional dose of calcitriol treatment, the observation group were treated with high dose of calcitriol. The differences of calcium and phosphorus levels, parathyroid hormone (PTH) level and quality of life were observed between the two groups before and after treatment. Results The serum phosphorus, calcium and calcium-phosphorus product in two groups of patients before treatment had no significant difference. After treatment, the above indicators decreased in two groups of patients compared with those before treatment, and the observation group was significantly lower (P<0.05). Before treatment, there was no difference in the levels of PTH between the two groups. After treatment, the level of PTH in the observation group was lower than that in the control group, and the difference was statistically significant (P<0.05). There was no significant difference in quality of life between the two groups before treatment. After treatment, the quality of life in the two groups were higher than before treatment, and the observation group was significantly higher (P<0.05). Conclusion High dose of calcitriol has good therapeutic effect for ESRD patients with SHPT and can significantly improve the patient's calcium and phosphorus and PTH levels, improve the quality of life of patients.
